| pubmed-article:16052193 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0087009 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0012155 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0043096 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0542559 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0074493 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0302614 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C1706050 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C2348042 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:16052193 | lifeskim:mentions | umls-concept:C0181090 | lld:lifeskim |
| pubmed-article:16052193 | pubmed:dateCreated | 2005-7-29 | lld:pubmed |
| pubmed-article:16052193 | pubmed:abstractText | Very-low-calorie diets (VLCDs) are used to promote short-term weight loss in obese patients. However, long-term maintenance of weight loss is generally poor. We assessed the efficacy and safety of sibutramine in maintaining weight loss achieved in obese patients by means of a 3-month VLCD. | lld:pubmed |
| pubmed-article:16052193 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16052193 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16052193 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16052193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16052193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16052193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16052193 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16052193 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16052193 | pubmed:issn | 0954-3007 | lld:pubmed |
| pubmed-article:16052193 | pubmed:author | pubmed-author:Mathus-Vliege... | lld:pubmed |
| pubmed-article:16052193 | pubmed:author | pubmed-author:Balance... | lld:pubmed |
| pubmed-article:16052193 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16052193 | pubmed:volume | 59 Suppl 1 | lld:pubmed |
| pubmed-article:16052193 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16052193 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16052193 | pubmed:pagination | S31-8; discussion S39 | lld:pubmed |
| pubmed-article:16052193 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:meshHeading | pubmed-meshheading:16052193... | lld:pubmed |
| pubmed-article:16052193 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16052193 | pubmed:articleTitle | Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. | lld:pubmed |
| pubmed-article:16052193 | pubmed:affiliation | Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. e.mathus-vliegen@amc.uva.nl | lld:pubmed |
| pubmed-article:16052193 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16052193 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16052193 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16052193 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16052193 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16052193 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16052193 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16052193 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16052193 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16052193 | lld:pubmed |
